New combo therapy shows promise for Tough-to-Treat cancer spread
NCT ID NCT06376292
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a combination of whole-brain radiation and a chemotherapy drug (thiotepa) injected into the spinal fluid for people with solid tumors that spread to the lining of the brain and spinal cord. 58 participants received this treatment along with their regular cancer therapy. The goal was to see if the combination was safe and effective at controlling the disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID TUMOR LEPTOMENINGEAL METASTASIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The Second Affiliated Hospital of Zhejiang University
Hangzhou, Zhejiang, 310000, China